Diabetes
Across
- 1. Route of administration of meglitinide analogs, metformin, alpha-glucosidase inhibitors, TZDs, DPP-4 inhibitors...
- 5. Focal ischemia / Manifestation such as: pain, asymmetric weakness; wasting of iliopsoas, quadriceps, and adductor muscles
- 9. abbreviation of a hyperglycemia state caused by hyperglycemia
- 10. plasma glucose test that is used for nonpregnant adults; patient requires to stop eating 8 hours before test ( Test needs to be done twice of value > 126 mg/dL to be dx as DM)
- 11. Initial antidiabetic therapy that's recommended to DM type 2; is a type of insulin sensitizers
- 13. Route of administration of Increatin mimetics and amylin
- 15. Delay in gastric emptying - one of the cause of hypoglycemia
- 19. Often is the first indicator of chronic graft injection; presence of protein in urine
- 22. ... maneuver; teach patient with retinopathy to avoid this maneuver because it increases blood pressure ---> causing vitreuos hemorrhage
- 24. Increased fat deposits in the skin, often caused by not rotating insulin injection site
- 27. the most common precipitating factor for development of DKA
- 28. Insulin secretagogue agent that stimulates insulin release; second-generation agents are often used
- 29. microvascular complication leading to kidney dysfunction
- 32. Short-acting antidiabetic med that increases insulin secretion
- 33. amount of time ( in minutes) insulin Lispro,or Aspart should be given before meal-time (spell number out)
- 34. This long-acting type of insulin should NOT be mixed with any other forms of insulin
- 35. Basal insulin coverage is often provided by this type of insulin
- 36. microvascular complication leading to nerve dysfunction
- 37. Condition that's defined as having IFG of 100-125 mg/dL, and IGT of 140-199mg/dL
- 40. Neuropathy type that affects a single nerve or nerve entrapment
- 41. abbreviation of a diabetic condition that is characterized by uncontrolled hyperglycemia, metabolic acidosis, and increased production of ketones. This condition results from the combination of insulin deficiency and an increase in counterregulatory hormones.
- 43. A drug in the alpha-glucosidase inhibitors class
Down
- 2. The fastest absorption site of insulin injection
- 3. Excessive eating
- 4. main counterregulatory hormone; overtime type1 DM patients' pancreas lose the ability to make this hormone in response to hypoglycemia
- 6. Type of respiration r/t metabolic acidosis
- 7. Type of neuropathy that involve widespread nerve function ( the most common neuropathy in DM patient)
- 8. a type of insulin sensitizers that increases cellular utilization of glucose; side effects are increase in adipose tissue, fluid retention and weight gain
- 12. this type of symptoms result from autonomic nervous activity triggered by a rapid decline in blood glucose; such as: shaky/ tremulous, heart pounding, sweaty, hungry, tingling
- 14. this type of symptoms occur when brain glucose gradually declines to a low level; such as: weakness, difficulty thinking, confusion, seizures, loss of consciousness
- 16. microvascular complication leading to vision problem
- 17. Increased protein or nitrogen waste products in the blood
- 18. age-related farsightedness, often made worse by burred vision caused by fluctuating blood glucose
- 20. Burning, stinging, or stabbing pain / Sensory alteration / Distal symmetric polyneuropathy
- 21. Test that reflects the amount of glucose binding to serum protein; is helpful in indicating tight control of blood glucose
- 23. Presence of albumin in urine, indication of kidney damage
- 25. Burning, tingling sensation that starts out in toes and moves up the extremities ( Sensory alterations / Distal symmetric polynneuropathies)
- 26. common type of electrolyte imbalances, often seen in patients with mild to moderate kidney failure
- 30. Excessive thirst
- 31. a test that measures how much glucose permanently attaches to a specific area of hemoglobin
- 37. Frequent and excessive urination
- 38. Phenomenon of blood glucose elevation at around 5-6AM caused by nigh time release of growth hormone
- 39. Phenomenon of morning hyperglycemia from the counterregulatory response to nighttime hypoglycemia
- 42. when this substance is present in urine, DM patient should not exercise